Gongwei Wu

1.8k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Gongwei Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gongwei Wu has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Gongwei Wu's work include Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). Gongwei Wu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). Gongwei Wu collaborates with scholars based in China, United States and Sweden. Gongwei Wu's co-authors include Ping Gao, Huafeng Zhang, Libing Song, Linchong Sun, Xiaoping He, Xiuying Zhong, Wei Tao, Na Kong, De Huang and Shengqi Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Gongwei Wu

17 papers receiving 1.3k citations

Hit Papers

Intravesical delivery of KDM6A -mRNA via mucoadhesive nan... 2022 2026 2023 2024 2022 40 80 120

Peers

Gongwei Wu
En‐Chi Hsu United States
Yun Zhou China
Rajesh Mukthavaram United States
Gongwei Wu
Citations per year, relative to Gongwei Wu Gongwei Wu (= 1×) peers Judong Luo

Countries citing papers authored by Gongwei Wu

Since Specialization
Citations

This map shows the geographic impact of Gongwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gongwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gongwei Wu more than expected).

Fields of papers citing papers by Gongwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gongwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gongwei Wu. The network helps show where Gongwei Wu may publish in the future.

Co-authorship network of co-authors of Gongwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Gongwei Wu. A scholar is included among the top collaborators of Gongwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gongwei Wu. Gongwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Korell, Felix, Irene Scarfò, Harrison Silva, et al.. (2025). Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma. Leukemia. 39(10). 2452–2464. 1 indexed citations
2.
Jiang, Baishan, David M. Weinstock, Katherine A. Donovan, et al.. (2023). ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas. Cell chemical biology. 30(4). 383–393.e6. 8 indexed citations
3.
Liu, Haijun, Wei Chen, Gongwei Wu, et al.. (2023). Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects. Advanced Science. 10(16). e2207439–e2207439. 57 indexed citations
4.
Kong, Na, Ruonan Zhang, Gongwei Wu, et al.. (2022). Intravesical delivery of KDM6A -mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. Proceedings of the National Academy of Sciences. 119(7). 128 indexed citations breakdown →
5.
Liu, Zhaoji, Linchong Sun, Yongping Cai, et al.. (2021). Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1. Cancer Research. 81(5). 1265–1278. 42 indexed citations
6.
Wu, Gongwei, Caixia Suo, Ying Yang, et al.. (2021). MYC promotes cancer progression by modulating m 6 A modifications to suppress target gene translation. EMBO Reports. 22(3). e51519–e51519. 33 indexed citations
7.
LIU, Chuang, Shan Sun, Qiang Feng, et al.. (2021). Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy (Adv. Mater. 37/2021). Advanced Materials. 33(37). 22 indexed citations
8.
LIU, Chuang, Shan Sun, Qiang Feng, et al.. (2021). Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy. Advanced Materials. 33(37). e2102054–e2102054. 111 indexed citations
9.
Huang, Xiangang, Gongwei Wu, Chuang LIU, et al.. (2021). Intercalation-Driven Formation of siRNA Nanogels for Cancer Therapy. Nano Letters. 21(22). 9706–9714. 41 indexed citations
10.
Wu, Gongwei, Shengqi Shen, Xiaoyu Ma, et al.. (2017). Menin enhances c-Myc-mediated transcription to promote cancer progression. Nature Communications. 8(1). 15278–15278. 46 indexed citations
11.
Zhong, Xiuying, Xiang Zhang, Xinwei Diao, et al.. (2017). CUE domain‐containing protein 2 promotes the Warburg effect and tumorigenesis. EMBO Reports. 18(5). 809–825. 19 indexed citations
12.
Huang, De, Tingting Li, Lin Wang, et al.. (2016). Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress. Cell Research. 26(10). 1112–1130. 123 indexed citations
13.
Sun, Linchong, Libing Song, Qianfen Wan, et al.. (2015). cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Research. 25(4). 429–444. 239 indexed citations
14.
Ma, Xiaoyu, Chenchen Li, Linchong Sun, et al.. (2014). Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nature Communications. 5(1). 5212–5212. 144 indexed citations
15.
Gao, Yijun, Qian Xiao, Li Li, et al.. (2010). LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proceedings of the National Academy of Sciences. 107(44). 18892–18897. 154 indexed citations
16.
Xu, Cailu, Gongwei Wu, Zheng Liu, et al.. (2004). Preparation of copper nanoparticles on carbon nanotubes by electroless plating method. Materials Research Bulletin. 39(10). 1499–1505. 77 indexed citations
17.
Cao, Anyuan, Lijie Ci, Gongwei Wu, et al.. (2001). An effective way to lower catalyst content in well-aligned carbon nanotube films. Carbon. 39(1). 152–155. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026